This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2013 Nov;13(11):917-8.

doi: 10.1016/S1473-3099(13)70289-5.

Adjunctive treatment of severe sepsis

Mark Dinubile¹

Affiliations

Affiliation

¹ Global Scientific and Medical Publications, Office of the Chief Medical Officer, Merck Sharp & Dohme Corp, UG3C-06, 351 North Sumneytown Pike, North Wales, PA 19454-2502, USA. Electronic address: mark_dinubile@merck.com.

PMID: 24156894
DOI: 10.1016/S1473-3099(13)70289-5

Comment

Adjunctive treatment of severe sepsis

Mark Dinubile. Lancet Infect Dis. 2013 Nov.

. 2013 Nov;13(11):917-8.

doi: 10.1016/S1473-3099(13)70289-5.

Author

Mark Dinubile¹

Affiliation

¹ Global Scientific and Medical Publications, Office of the Chief Medical Officer, Merck Sharp & Dohme Corp, UG3C-06, 351 North Sumneytown Pike, North Wales, PA 19454-2502, USA. Electronic address: mark_dinubile@merck.com.

PMID: 24156894
DOI: 10.1016/S1473-3099(13)70289-5

No abstract available

PubMed Disclaimer

Comment on

Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach.
Hotchkiss RS, Monneret G, Payen D. Hotchkiss RS, et al. Lancet Infect Dis. 2013 Mar;13(3):260-8. doi: 10.1016/S1473-3099(13)70001-X. Lancet Infect Dis. 2013. PMID: 23427891 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information